BiotechTube
Home/Kaerus Bioscience/Marc Ceusters
MC

Marc Ceusters

Head of Development

Kaerus Bioscience

Therapeutic Areas

Neurodevelopmental DisordersRare Genetic Diseases

Kaerus Bioscience Pipeline

DrugIndicationPhase
KER-0193Fragile X syndromePreclinical
BK Channel ModulatorKCNMA1-linked ChannelopathiesPreclinical

Leadership Team at Kaerus Bioscience

RH
Robert H. Ring
Chief Executive Officer
VG
Valentin Gribkoff
Ion Channel Pharmacology
NS
Nicholas Stern
Chief Financial Officer
View full Kaerus Bioscience profile